Literature DB >> 17893331

Suppression of p53-dependent senescence by the JNK signal transduction pathway.

Madhumita Das1, Feng Jiang, Hayla K Sluss, Chao Zhang, Kevan M Shokat, Richard A Flavell, Roger J Davis.   

Abstract

The JNK signaling pathway is implicated in the regulation of the AP1 transcription factor and cell proliferation. Here, we examine the role of JNK by using conditional and chemical genetic alleles of the ubiquitously expressed murine genes that encode the isoforms JNK1 and JNK2. Our analysis demonstrates that JNK is not essential for proliferation. However, JNK is required for expression of the cJun and JunD components of the AP1 transcription factor, and JNK-deficient cells exhibit early p53-dependent senescence. These data demonstrate that JNK can act as a negative regulator of the p53 tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893331      PMCID: PMC2000443          DOI: 10.1073/pnas.0707782104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity.

Authors:  D P Silver; D M Livingston
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

Review 3.  The JNK signal transduction pathway.

Authors:  Claire R Weston; Roger J Davis
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

4.  JunD protects cells from p53-dependent senescence and apoptosis.

Authors:  J B Weitzman; L Fiette; K Matsuo; M Yaniv
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

Review 5.  AP-1 in mouse development and tumorigenesis.

Authors:  W Jochum; E Passegué; E F Wagner
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

6.  Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.

Authors:  C Tournier; P Hess; D D Yang; J Xu; T K Turner; A Nimnual; D Bar-Sagi; S N Jones; R A Flavell; R J Davis
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

Review 7.  The INK4a/ARF network in tumour suppression.

Authors:  C J Sherr
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

8.  Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts.

Authors:  Patricia Hess; German Pihan; Charles L Sawyers; Richard A Flavell; Roger J Davis
Journal:  Nat Genet       Date:  2002-08-05       Impact factor: 38.330

Review 9.  Targeting JNK for therapeutic benefit: from junk to gold?

Authors:  Anthony M Manning; Roger J Davis
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

10.  A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse.

Authors:  Tudor C Badea; Yanshu Wang; Jeremy Nathans
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more
  76 in total

1.  A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice.

Authors:  Qian Qi; Weishan Huang; Yuting Bai; Gabriel Balmus; Robert S Weiss; Avery August
Journal:  J Immunol       Date:  2012-03-07       Impact factor: 5.422

2.  Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.

Authors:  Cristina Cellurale; Guadalupe Sabio; Norman J Kennedy; Madhumita Das; Marissa Barlow; Peter Sandy; Tyler Jacks; Roger J Davis
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

3.  Allosteric Modulation of JNK Docking Site Interactions with ATP-Competitive Inhibitors.

Authors:  Chloe K Lombard; Audrey L Davis; Takayuki Inukai; Dustin J Maly
Journal:  Biochemistry       Date:  2018-09-25       Impact factor: 3.162

4.  The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.

Authors:  Hengning Ke; Rebecca Harris; Jonathan L Coloff; Jane Y Jin; Benjamin Leshin; Paula Miliani de Marval; Shiying Tao; Jeffrey C Rathmell; Russell P Hall; Jennifer Y Zhang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

5.  dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.

Authors:  Giulia Santinon; Irene Brian; Arianna Pocaterra; Patrizia Romani; Elisa Franzolin; Chiara Rampazzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2018-04-12       Impact factor: 11.598

6.  The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.

Authors:  Jennifer Y Zhang; Maria Angelica Selim
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

7.  Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1.

Authors:  Guadalupe Sabio; Julie Cavanagh-Kyros; Tamera Barrett; Dae Young Jung; Hwi Jin Ko; Helena Ong; Caroline Morel; Alfonso Mora; Judith Reilly; Jason K Kim; Roger J Davis
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

8.  Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages.

Authors:  Katya B Rubinow; Valerie Z Wall; Joel Nelson; Daniel Mar; Karol Bomsztyk; Bardia Askari; Marvin A Lai; Kelly D Smith; Myoung Sook Han; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Carolyn J Albert; David A Ford; Roger J Davis; Karin E Bornfeldt
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

9.  Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.

Authors:  Shigeo Ohba; Yuichi Hirose; Takeshi Kawase; Hirotoshi Sano
Journal:  J Neurooncol       Date:  2009-06-11       Impact factor: 4.130

10.  Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.

Authors:  Lijuan Chen; Siqing Wang; Yiming Zhou; Xiaosong Wu; Igor Entin; Joshua Epstein; Shmuel Yaccoby; Wei Xiong; Bart Barlogie; John D Shaughnessy; Fenghuang Zhan
Journal:  Blood       Date:  2009-10-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.